MRKR · Marker Therapeutics Inc
United States · RS rating 28 · As of 2026-11-03
| Price | 0.98 USD |
|---|---|
| 1-day change | +9.2% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 40 / 39 / 50 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 6 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +43.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +55.1% |
| Market cap (USD) | $24.2M |